Adults with OSA continue to benefit from novel surgery three years on: Aussie study
Patients with obstructive sleep apnoea treated with a novel surgical technique have persistent long-term symptom improvements up to 3.5 years post-surgery, Australian doctors report.
Although the combination upper airway procedure was not curative, the researchers said the benefits lasted “well beyond” the initial six-month trial period without waning in those who failed CPAP therapy.
“The benefits include improvement in sleep apnoea markers and daytime sleepiness, and possibly secondary benefits of less snoring and improved general health,” said co-author Professor Stuart MacKay, from the Illawarra ENT Head and Neck Clinic in Wollongong.
The team compared outcomes for 91 adults in the Sleep Apnea Multilevel Surgery trial who had moderate or severe obstructive sleep apnoea (OSA).
